CeriBell, Inc. (CBLL)
Health Services • Health Care
August 03, 2026 CeriBell, Inc. Secures New Technology Add-On Payment for Delirium Monitor System CeriBell, Inc. has received a New Technology Add-on Payment from CMS for its FDA-cleared Delirium Monitor System, enhancing reimbursement for neurological care. This innovative technology allows for continuous EEG monitoring, supporting timely treatment decisions for critically ill patients. The payment structure will take effect on October 1, 2026, furthering CeriBell's mission to improve patient outcomes.
July 29, 2026 CeriBell, Inc. Welcomes New Leadership to Board of Directors CeriBell, Inc. has appointed Thomas West and Sharon O’Keefe to its Board of Directors, bringing extensive experience in medical technology and healthcare systems. Their expertise is expected to drive innovation and growth as CeriBell expands its point-of-care brain monitoring technology across hospitals.
July 28, 2026 CeriBell, Inc. to Showcase Innovations at Canaccord Genuity 46th Annual Growth Conference CeriBell, Inc. will participate in the Canaccord Genuity 46th Annual Growth Conference, showcasing its innovative EEG solutions. CFO Scott Blumberg will discuss the company's impact on neurological care and its commitment to improving patient outcomes.
July 20, 2026 CeriBell, Inc. Set to Announce Second Quarter 2026 Financial Results CeriBell, Inc. is set to release its Q2 2026 financial results on August 10, with a conference call scheduled for investors. The company is known for its innovative EEG platform designed for urgent neurological care.
June 08, 2026 CeriBell, Inc. Releases Landmark Study Linking AI-Based Seizure Monitoring to Patient Outcomes CeriBell, Inc. released a landmark study showing that its AI-based Clarity algorithm effectively measures seizure burden, correlating it with patient outcomes in critical care. The findings highlight the significance of timely intervention in managing seizures and improving prognosis for patients in emergency settings.
May 20, 2026 CeriBell, Inc. to Showcase Innovations at William Blair Annual Growth Stock Conference CeriBell, Inc. will present its innovative EEG technology at the William Blair Annual Growth Stock Conference on June 3, 2026. CEO Dr. Jane Chao will discuss advancements in neurological diagnostics aimed at improving patient outcomes in critical care settings.